Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
09/2010
09/28/2010US7803543 Methods and kits for the detection of nucleotide mutations using peptide nucleic acid as both PCR clamp and sensor probe
09/28/2010US7803542 Bioelectronic detectors based on oligonucleotides including synthetic and naturally-occurring nucleotide polymers such as aptamers, DNA, and RNA and their use to detect molecular targets via target-induced strand displacement.
09/28/2010US7803541 Different nucleic acids are captured through cooperative hybridization events on different, identifiable subsets of particles or at different selected positions on a spatially addressable solid support.
09/28/2010US7803540 Immobilizing first and second probes on a substrate, hybridizing the probes with first and second hurdle DNAs probes, hybridizing the target DNA with the hybrids, and determining the ratio of a signal of the target DNA hybridized to the first probe to a signal of the DNA hybridized to the second probe
09/28/2010US7803539 Method of isolating and purifying nucleic acids using immobilized hydrogel or PEG-hydrogel copolymer
09/28/2010US7803538 Using mutation in atp-binding cassette-2 genes as diagnostic indicator of neurodegenerative diseases; single nucleotide polymorphisms and nervous system disorders
09/28/2010US7803537 by direct sample immobilization onto microspheres of an array comprising a patterned surface of discrete sites that can associate the individual microspheres
09/28/2010US7803536 Methods of detecting fluorescence with anthraquinone quencher dyes
09/28/2010US7803535 Predicting the likelihood of an incidence of graft versus host diseases by detecting the presence at least one of the polymorphisms Nod2-SNP8, Nod2-SNP12, Nod2-SNP13 in the NOD2/CARD15 gene
09/28/2010US7803534 Method of judging biological activity in bioremediation site and polynucleotide for detecting microorganism to be used therein
09/28/2010US7803533 Diagnostic agent for malignant melanoma
09/28/2010US7803532 Diagnosis of Sezary syndrome (a type of lymphoma) by analyzing a nucleic acid sample from a human patient to detect the presence or the absence of a neuron navigator 3 gene and diagnosing Sezary syndrome when the gene is absent
09/28/2010US7803531 Anticancer, antitumor agents
09/28/2010US7803530 Detection and typing of human papillomavirus using PNA probes
09/28/2010US7803529 Hybridizing the nucleic acids which represent complementary or homologous sequences of the target to an array of nucleic acid probes with a single-stranded portion having a variable region; molecular weight determined by mass spectrometry; target sequence determined from fragment molecular weights
09/28/2010US7803528 Real-time monitoring of nucleic acid amplification using a first probe that is a fluorophore capable of hybridizing to the nucleic acid, and a second probe capable of hybridizing to the first probe, has a molecule which quenches said first probe, and is longer than the first probe; detectng fluorescence
09/28/2010US7803527 Inactivated bovine herpes virus-1 and methods
09/28/2010US7803526 Development of diagnostic kit for the detection of Chrysanthemum virus B
09/28/2010US7803525 Detecting a specific nucleic acid sequence of at least 13 contiguous nucleotides or the reverse complement sequence by using quantitative real-time reverse transcriptase polymerase chain reaction
09/28/2010US7803524 Diagnostic compositions containing the polypeptide conjugated to a detectable label, such as radioisotopes, enzymes, fluorescent labels, antibody conjugates, or substrates
09/28/2010US7803388 Polymorphic membrane proteins or PMPs of Chlamydia, amino acid and nucleotide sequences; immunogens; vaccines; biodrugs;respiratory system disorders; urogenital system disorders; genetic engineering
09/28/2010US7803387 With proteins of nisseria and purification of domains and gene expression of oligopeptides of ser, lys, ala, glu, gly and met
09/28/2010US7803379 Tumour-specific animal proteins
09/28/2010US7803373 Chemokine panec-1 antibodies
09/28/2010US7803370 Method for treating synovial sarcoma
09/28/2010CA2415493C Cation mediated triplex hybridization assay
09/28/2010CA2407726C Sulfonated [8,9]benzophenoxazine dyes and the use of their labelled conjugates
09/28/2010CA2407124C Denaturant-free electrophoresis of biological molecules under high temperature conditions
09/28/2010CA2384756C Reversed-phase hplc assay for plasminogen activators
09/28/2010CA2326821C Nucleic acid encoding hyaluronan synthase and methods of use
09/28/2010CA2274246C Identification of salmonella
09/28/2010CA2235866C Methods of treating established colitis using antibodies against il-12
09/28/2010CA2188017C Cardiotrophin and uses therefor
09/27/2010CA2660622A1 Rig-i mutations and uses thereof in diagnostic and therapeutic virus-dependent immune applications
09/25/2010CA2697851A1 Composition and method for modulating plant transformation
09/25/2010CA2697848A1 Composition and method for modulating plant transformation
09/23/2010WO2010108192A1 Mirnas as therapeutic targets in cancer
09/23/2010WO2010108143A2 Global mapping of protein-dna interaction by digital genomic footprinting
09/23/2010WO2010108025A2 Aligning cells on wrinkled surface
09/23/2010WO2010108003A2 Device for capturing circulating cells
09/23/2010WO2010107979A1 Detection device and method for detecting analyte
09/23/2010WO2010107946A2 Use of thermostable endonucleases for generating reporter molecules
09/23/2010WO2010107825A2 Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities
09/23/2010WO2010107816A2 Nucleic acid binding dyes and uses therefor
09/23/2010WO2010107740A2 Treatment of delta-like 1 homolog (dlk1) related diseases by inhibition of natural antisense transcript to dlk1
09/23/2010WO2010107733A2 Treatment of nuclear factor (erythroid-derived 2)-like 2 (nrf2) related diseases by inhibition of natural antisense transcript to nrf2
09/23/2010WO2010107716A2 Abscription based molecular detection
09/23/2010WO2010107497A2 Honeycomb shrink wells for stem cell culture
09/23/2010WO2010107476A1 Inhibiting gsnor
09/23/2010WO2010107443A1 Renal cell carcinoma biomarkers
09/23/2010WO2010107398A1 Point of care test for the detection of exposure to hev immunoglobulin a (iga)
09/23/2010WO2010107385A1 Method for detection of an enzyme-substrate reaction
09/23/2010WO2010107292A1 In vitro method for the detection of candida glabrata, diagnostic kit and use thereof
09/23/2010WO2010107113A1 Retroelement polymorphism detection method
09/23/2010WO2010106997A1 Method, kit and device for detecting nucleic acid
09/23/2010WO2010106788A1 Fertility test method, fertility test kit, polynucleotide, polypeptide and antibody
09/23/2010WO2010106222A2 Biotinidase assay
09/23/2010WO2010106176A1 Msh2 and adjuvant cisplatin-based chemotherapy in non-small-cell lung cancer
09/23/2010WO2010106162A1 Process and apparatus for testing substances for potential carcinogenicity
09/23/2010WO2010106109A1 Multi-use of biochips
09/23/2010WO2010105851A1 Probe compound for detecting and isolating enzymes and means and methods using the same
09/23/2010WO2010105850A2 Test element for determining a body fluid and measurement method
09/23/2010WO2010105815A2 Improved detection of gene expression
09/23/2010WO2010105724A1 In vitro methods for determining an intracellular free magnesium deficiency of individuals by determining the expression rate of a cellular mg2+ transporter gene
09/23/2010WO2010105315A2 Reporter gene constructs for pet
09/23/2010WO2010105298A1 Peptidase inhibitor 16 (pi16) as a biomarker for regulatory t (treg) cells and uses thereof
09/23/2010WO2010088668A3 Methods of detecting sepsis
09/23/2010WO2010087888A3 Development of low allergen soybean seeds using molecular markers for the p34 allele
09/23/2010WO2010086512A3 Lactobacillus rhamnosus pilus polypeptides and methods for producing them
09/23/2010WO2010081662A3 Methods for identifying patients who will respond well to cancer treatment
09/23/2010WO2010079084A3 Method for identifying genes involved in trail-induced apoptosis and therapeutic applications thereof
09/23/2010WO2010067969A3 Novel use of the loc284422 gene
09/23/2010WO2010065776A3 Identification of neuroprotective agents using pro-inflammatory human glial cells
09/23/2010WO2010062697A3 Membrane-integrated viral dna-packaging motor protein connector biosensor for dna sequencing and other uses
09/23/2010WO2010059242A3 Neurodegenerative disease diagnostic compositions and methods of use
09/23/2010WO2010058968A3 Method for selecting optimum heavy metal adsorption condition for gram positive bacteria using qicar modeling, and adsorption method using the same
09/23/2010WO2010057152A8 Cross-species chimeric rna molecules
09/23/2010WO2010057135A3 Methods and compositions for predicting a subject's susceptibility to and risk of developing type 2 diabetes
09/23/2010WO2010056374A3 Methods and compositions of molecular profiling for disease diagnostics
09/23/2010WO2010031988A3 Polypeptides substrates of lrrk2 and uses thereof
09/23/2010WO2009117798A3 Fluorescent nanoparticle composites themselves, process for the preparation of such composites, and use in rapid diagnosis systems with affinity to biological molecules
09/23/2010WO2001051665A9 Nanoparticles having oligonucleotides attached thereto and uses therefor
09/23/2010US20100242140 Modulation Of Plant Cell Wall Deposition
09/23/2010US20100242139 Xenohormesis based compositions and methods
09/23/2010US20100242136 Udp-glucose modifiers
09/23/2010US20100242134 Methods and polynucleotides for improving plants
09/23/2010US20100242128 Method to produce modified plants with altered n-glycosylation pattern
09/23/2010US20100242127 Methods to identify modulators of b-raf protein kinase and their use for the treatment of anxiety and depression
09/23/2010US20100242126 Regulator of ephrin-Eph receptor signaling and mouse having abnormal ephrin-Eph receptor signaling mechanisms
09/23/2010US20100242124 Compositions and methods for the treatment and prevention of ulcerative colitis and colon cancer and screening methods to identify same
09/23/2010US20100241101 Method and a blood oxygen tester for detecting the arterial or venous blood
09/23/2010US20100241026 Portable suction device
09/23/2010US20100241016 System for quantifying blood flow in tissue and updating tissue baseline conditions
09/23/2010US20100240881 Therapeutic compositions
09/23/2010US20100240876 Replikins and methods of identifying replikin-containing sequences
09/23/2010US20100240873 Ligand (act-4-l) to a receptor on the surface of activated cd4+ tcells
09/23/2010US20100240763 Method to Determine and Biomarker for Treatment Efficacy With Ssri, Snri, and Sari Antidepressants
09/23/2010US20100240760 Biomarkers for Efficacy of Aliskiren as a Hypertensive Agent
09/23/2010US20100240744 Methods for the treatment of dementia based on apo e genotype
09/23/2010US20100240734 Methods and compositions for the specific inhibition of gene expression by double-stranded rna